139 related articles for article (PubMed ID: 35410760)
41. Histolopathologic approach to direct the management of the axilla in early breast cancer patients.
Farid RM; Ahmed NS
APMIS; 2014 Oct; 122(10):1032-41. PubMed ID: 24698490
[TBL] [Abstract][Full Text] [Related]
42. Practice Patterns of Radiation Field Design for Sentinel Lymph Node-Positive Early-Stage Breast Cancer.
Azghadi S; Daly M; Mayadev J
Clin Breast Cancer; 2016 Oct; 16(5):410-417.e3. PubMed ID: 27266803
[TBL] [Abstract][Full Text] [Related]
43. Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.
Turashvili G; Brogi E; Morrow M; Dickler M; Norton L; Hudis C; Wen HY
BMC Cancer; 2018 Jan; 18(1):42. PubMed ID: 29304773
[TBL] [Abstract][Full Text] [Related]
44. Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer.
Park S; Lee JE; Paik HJ; Ryu JM; Bae SY; Lee SK; Kim SW; Nam SJ
Clin Breast Cancer; 2017 Feb; 17(1):e19-e29. PubMed ID: 27495997
[TBL] [Abstract][Full Text] [Related]
45. Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer.
Takei H; Suemasu K; Kurosumi M; Horii Y; Yoshida T; Ninomiya J; Yoshida M; Hagiwara Y; Kamimura M; Hayashi Y; Inoue K; Tabei T
Breast Cancer; 2007; 14(1):16-24. PubMed ID: 17244989
[TBL] [Abstract][Full Text] [Related]
46. Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy.
Han SN; Amant F; Cardonick EH; Loibl S; Peccatori FA; Gheysens O; Sangalli CA; Nekljudova V; Steffensen KD; Mhallem Gziri M; Schröder CP; Lok CAR; Verest A; Neven P; Smeets A; Pruneri G; Cremonesi M; Gentilini O;
Breast Cancer Res Treat; 2018 Apr; 168(2):551-557. PubMed ID: 29235045
[TBL] [Abstract][Full Text] [Related]
47. Technical feasibility of sentinel lymph node biopsy in patients with ipsilateral breast tumor recurrence and previous axillary surgery.
Matsumoto A; Jinno H; Nakamura T; Saito J; Takahashi M; Hayashida T; Kameyama K; Kitagawa Y
Int J Surg; 2015 Oct; 22():28-31. PubMed ID: 26278666
[TBL] [Abstract][Full Text] [Related]
48. "Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients".
van Wely BJ; van den Wildenberg FJ; Gobardhan P; van Dalen T; Borel Rinkes IH; Theunissen EB; Wijsman JH; Ernst M; van der Pol CC; Madsen EV; Vles WJ; Wauters CA; de Wilt JH; Strobbe LJ
Eur J Surg Oncol; 2012 Oct; 38(10):925-31. PubMed ID: 22633152
[TBL] [Abstract][Full Text] [Related]
49. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
50. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
[No Abstract] [Full Text] [Related]
51. Breast cancer larger than 2.5 cm with tumor-free radioisotope-hot sentinel nodes has higher risk of non-hot axillary lymph node metastasis.
Liu YL; Kuo WL; Lo YF; Tsai HP; Shen SC; Yu CC; Chou HH; Chu CH; Chen SC
Biomed J; 2022 Apr; 45(2):396-405. PubMed ID: 35562283
[TBL] [Abstract][Full Text] [Related]
52. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
[TBL] [Abstract][Full Text] [Related]
53. Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?
Hennigs A; Köpke M; Feißt M; Riedel F; Rezai M; Nitz U; Moderow M; Golatta M; Sohn C; Schneeweiss A; Heil J
Breast Cancer Res Treat; 2019 Jan; 173(2):429-438. PubMed ID: 30315437
[TBL] [Abstract][Full Text] [Related]
54. Axillary lymph node dissection vs. sentinel node biopsy for early-stage clinically node-negative breast cancer: a systematic review and meta-analysis.
Petousis S; Christidis P; Margioula-Siarkou C; Liberis A; Vavoulidis E; Margioula-Siarkou G; Vatopoulou A; Papanikolaou A; Mavromatidis G; Dinas K
Arch Gynecol Obstet; 2022 Oct; 306(4):1221-1234. PubMed ID: 35249123
[TBL] [Abstract][Full Text] [Related]
55. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.
Giuliano AE; Ballman K; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Morrow M; Hunt KK
Ann Surg; 2016 Sep; 264(3):413-20. PubMed ID: 27513155
[TBL] [Abstract][Full Text] [Related]
56. Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy.
Stauder MC; Caudle AS; Allen PK; Shaitelman SF; Smith BD; Hoffman KE; Buchholz TA; Chavez-Macgregor M; Hunt KK; Meric-Bernstam F; Woodward WA
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):637-44. PubMed ID: 27681760
[TBL] [Abstract][Full Text] [Related]
57. Second Axillary Sentinel Lymph Node Biopsy for Breast Tumor Recurrence: Experience of the European Institute of Oncology.
Intra M; Viale G; Vila J; Grana CM; Toesca A; Gentilini O; Galimberti V; Veronesi P; Luini A; Rotmensz N; Bagnardi V; Mattar D; Colleoni M
Ann Surg Oncol; 2015 Jul; 22(7):2372-7. PubMed ID: 25515197
[TBL] [Abstract][Full Text] [Related]
58. Late Axillary Recurrence After Negative Sentinel Lymph Node Biopsy is Uncommon.
Matsen C; Villegas K; Eaton A; Stempel M; Manning A; Cody HS; Morrow M; Heerdt A
Ann Surg Oncol; 2016 Aug; 23(8):2456-61. PubMed ID: 26957506
[TBL] [Abstract][Full Text] [Related]
59. Axillary dissection in sentinel lymph node positive breast cancer: Is the staging information worthwhile for patients?
Chang DW; Bressel M; Hansen C; Blinman P; Schofield P; Chua BH
Asia Pac J Clin Oncol; 2021 Apr; 17(2):e27-e34. PubMed ID: 31461222
[TBL] [Abstract][Full Text] [Related]
60. Management of the axilla following neoadjuvant chemotherapy for breast cancer- A change in practice.
Riogi B; Sripadam R; Barker D; Harris O; Innes H; Chagla L
Surgeon; 2021 Feb; 19(1):1-7. PubMed ID: 32192932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
